• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 7
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue7

Emerging Trends Of Liquid Crystalline Nanoparticles Drug Delivery For Pulmonary Disorders

    Vrinder Pal Singh Meenu Mehta Saurabh Satija Deep Shikha Sharma Pardeep Kumar Sharma

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 7, Pages 2558-2564

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

In this era of nanotechnology lyotropic liquid crystalline nanoparticles (cubosomes) are relatively less explored lipid-based nanocarriers that can be formulated selectively and specificity for almost all administration routes. The natural compounds are proved to be significantly curative in pulmonary diseases due to reported anti-oxidant, anti-inflammatory and immunomodulatory activities. The natural products have limited bioavailability due to either hydrophilic or low water solubility. These limitations can be overcome by using a novel nanotechnology such as cubosomes or liquid crystalline nanoparticles (LCNs). LCNs can easily encapsulate both hydrophilic and hydrophobic compounds because of the amphiphilic nature of lipid monoolein (MO). LCN can be used to co-deliver synthetic and natural compounds irrespective of their solubility due to multi-compartment structure. We can use LCNs to formulate drugs of synthetic origin with natural one to overcome multidrug resistance (MDR).
Keywords:
    Cubosomes liquid crystalline nanoparticles monoolein pulmonary diseases multidrug resistance lipid nanocarrier
  • PDF (256 K)
  • XML
(2020). Emerging Trends Of Liquid Crystalline Nanoparticles Drug Delivery For Pulmonary Disorders. European Journal of Molecular & Clinical Medicine, 7(7), 2558-2564.
Vrinder Pal Singh; Meenu Mehta; Saurabh Satija; Deep Shikha Sharma; Pardeep Kumar Sharma. "Emerging Trends Of Liquid Crystalline Nanoparticles Drug Delivery For Pulmonary Disorders". European Journal of Molecular & Clinical Medicine, 7, 7, 2020, 2558-2564.
(2020). 'Emerging Trends Of Liquid Crystalline Nanoparticles Drug Delivery For Pulmonary Disorders', European Journal of Molecular & Clinical Medicine, 7(7), pp. 2558-2564.
Emerging Trends Of Liquid Crystalline Nanoparticles Drug Delivery For Pulmonary Disorders. European Journal of Molecular & Clinical Medicine, 2020; 7(7): 2558-2564.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 120
  • PDF Download: 251
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus